Managing Metastatic Prostate Cancer In Your Urological Oncology Practice
This text provides a comprehensive review of pathophysiology, molecular and cell biology aspects of CRPC, discusses all major clinical trials that have led to approval of 6 new drugs since 2004, explores the role of bone preservation strategies, in depth analysis of combination and sequencing strate...
Συγγραφή απο Οργανισμό/Αρχή: | |
---|---|
Άλλοι συγγραφείς: | |
Μορφή: | Ηλεκτρονική πηγή Ηλ. βιβλίο |
Γλώσσα: | English |
Έκδοση: |
Cham :
Springer International Publishing : Imprint: Springer,
2016.
|
Θέματα: | |
Διαθέσιμο Online: | Full Text via HEAL-Link |
Πίνακας περιεχομένων:
- Introduction
- Pathophysiology of Castration-Resistant Prostate Cancer
- Androgen Receptor Signaling in Castration Resistant Prostate Cancer
- Non-Androgen Signaling Pathways in Castration-Resistant Prostate Cancer
- Predictive Models in Castration Resistant Prostate Cancer
- Docetaxel in Advanced and Castration Resistant Prostate Cancer
- Combination Treatment Strategies with Docetaxel in Patients with Metastatic Prostate
- Cancer Vaccines in Castration Resistant Prostate Cancer – An evolution in design
- Abiraterone for the treatment of mCRPC
- Enzalutamide in Metastatic Castration Resistant Prostate Cancer
- Radium-223 in Metastatic Castrate Resistant Prostate Cancer
- Cabazitaxel for the Treatment of Prostate Cancer
- Sequencing Therapies in Metastatic Castration Resistant Prostate Cancer
- Bone Preservation Strategies for Men on Androgen Deprivation Therapy
- Novel Therapies in Castration-Resistant Prostate Cancer.